Clarkston Capital Partners’s Eli Lilly LLY Stock Holding History

Clarkston Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,050	Closed	-$8.65M	–	145
2025 Q4	$8.65M	Sell	8,050 -2,000	-20%	-$1.91M	0.2%	73
2025 Q3	$7.67M	Hold	10,050	–	–	0.17%	69
2025 Q2	$7.83M	Buy	10,050 +50	+0.5%	+$38.9K	0.17%	65
2025 Q1	$8.26M	Hold	10,000	–	–	0.16%	60
2024 Q4	$7.72M	Sell	10,000 -75	-0.7%	-$62.1K	0.15%	58
2024 Q3	$8.93M	Hold	10,075	–	–	0.16%	55
2024 Q2	$9.12M	Hold	10,075	–	–	0.17%	53
2024 Q1	$7.84M	Hold	10,075	–	–	0.14%	55
2023 Q4	$5.87M	Buy	10,075 +75	+0.8%	+$43.8K	0.11%	52
2023 Q3	$5.37M	Hold	10,000	–	–	0.11%	55
2023 Q2	$4.69M	Hold	10,000	–	–	0.08%	53
2023 Q1	$3.43M	Hold	10,000	–	–	0.06%	55
2022 Q4	$3.66M	Hold	10,000	–	–	0.07%	55
2022 Q3	$3.23M	Hold	10,000	–	–	0.06%	54
2022 Q2	$3.24M	Sell	10,000 -100	-1%	-$30K	0.06%	54
2022 Q1	$2.89M	Buy	+10,100	New	+$2.6M	0.05%	61
2017 Q1	–	Sell	-10,000	Closed	-$736K	–	110
2016 Q4	$736K	Hold	10,000	–	–	0.04%	84
2016 Q3	$803K	Hold	10,000	–	–	0.04%	81
2016 Q2	$788K	Hold	10,000	–	–	0.04%	79
2016 Q1	$720K	Sell	10,000 -750	-7%	-$56.8K	0.04%	85
2015 Q4	$906K	Hold	10,750	–	–	0.06%	77
2015 Q3	$900K	Hold	10,750	–	–	0.08%	82
2015 Q2	$898K	Sell	10,750 -600	-5%	-$45.7K	0.09%	86
2015 Q1	$825K	Buy	11,350 +1,150	+11%	+$81.9K	0.09%	88
2014 Q4	$704K	Hold	10,200	–	–	0.11%	111
2014 Q3	$661K	Hold	10,200	–	–	0.11%	95
2014 Q2	$634K	Hold	10,200	–	–	0.12%	99
2014 Q1	$600K	Buy	+10,200	New	+$569K	0.12%	101

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clarkston Capital Partners's LLY Position: Q1 2026 in Review

Clarkston Capital Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 8,050 shares — an estimated $8.65M sold.

Clarkston Capital Partners first reported a position in LLY in Q1 2014 and held it in 28 quarters. The position peaked at $9.12M in Q2 2024. 4,385 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Clarkston Capital Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Clarkston Capital Partners sold 8,050 Eli Lilly shares in Q1 2026, an estimated $8.65M.
Clarkston Capital Partners first reported a position in Eli Lilly in Q1 2014 and held it in 28 quarters.
Clarkston Capital Partners's Eli Lilly position peaked at $9.12M in Q2 2024.
4,385 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Clarkston Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.